← Open Payments lookup

ROBYN CRISP: Open Payments

NPI 1144705922 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 15 payments from 12 companies in 2025. Trend: 2023 $523 · 2024 $186 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
Janssen Biotech, Inc.1$135
Bayer Healthcare Pharmaceuticals Inc.1$109
Daiichi Sankyo Inc.2$46
Genentech USA, Inc.2$46
AstraZeneca Pharmaceuticals LP2$41
Legend Biotech USA Inc.1$33
Ipsen Biopharmaceuticals, Inc1$29
Merck Sharp & Dohme LLC1$25
Syndax Pharmaceuticals, Inc.1$23
Astellas Pharma US Inc1$21

Products named: RYBREVANT, Nubeqa, Vanflyta, CARVYKTI, Onivyde, KEYTRUDA, Venclexta, REVUFORJ.

Industry payments across DE — which companies pay providers there.